Abstract
Although evidence-based asthma guidelines report passive smoke exposure as one of the triggers of asthma symptoms and exacerbations, its prevelance is still high among children with asthma especially in those coming from low income families. Passive smoke exposure affects different aspects of asthma control not only diurnal and nocturnal symptoms and exacerbations but also rescue medication use and lung functions as well as bronchial hyperreactivity, school absenteeism and quality of life. Immediate effects of passive smoke exposure in all these asthma parameters seem to be additive to those of chronic exposure. Smoking cessation interventions therefore play a pivotal role for a better asthma control.
Keywords: Asthma, children, environmental tobacco smoke, exacerbation, lung function
Inflammation & Allergy - Drug Targets (Discontinued)
Title: Acute Effects of Passive Smoking on Asthma in Childhood
Volume: 8 Issue: 5
Author(s): Arzu Bakirtas
Affiliation:
Keywords: Asthma, children, environmental tobacco smoke, exacerbation, lung function
Abstract: Although evidence-based asthma guidelines report passive smoke exposure as one of the triggers of asthma symptoms and exacerbations, its prevelance is still high among children with asthma especially in those coming from low income families. Passive smoke exposure affects different aspects of asthma control not only diurnal and nocturnal symptoms and exacerbations but also rescue medication use and lung functions as well as bronchial hyperreactivity, school absenteeism and quality of life. Immediate effects of passive smoke exposure in all these asthma parameters seem to be additive to those of chronic exposure. Smoking cessation interventions therefore play a pivotal role for a better asthma control.
Export Options
About this article
Cite this article as:
Bakirtas Arzu, Acute Effects of Passive Smoking on Asthma in Childhood, Inflammation & Allergy - Drug Targets (Discontinued) 2009; 8 (5) . https://dx.doi.org/10.2174/1871528110908050353
DOI https://dx.doi.org/10.2174/1871528110908050353 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Pharmacogenomics and Personalized Medicine for the Developing World - Too Soon or Just-in-Time? A Personal View from the World Health Organization
Current Pharmacogenomics and Personalized Medicine Anti-IgE Therapy in Allergic Asthma
Current Drug Targets - Inflammation & Allergy T and B-cell Epitopes Prediction of Iranian Saffron (Crocus sativus) Profilin by Bioinformatics Tools
Protein & Peptide Letters Inhaled Dry Powder Formulations for Treating Tuberculosis
Current Drug Delivery GABAB Receptors as Potential Therapeutic Targets
Current Drug Targets - CNS & Neurological Disorders Identification of Antioxidative Components in <i>ChuanKeZhi</i> Injection and Discussion on Its Quality Control Method
Current Pharmaceutical Analysis Telemedicine, Genomics and Personalized Medicine: Synergies and Challenges
Current Pharmacogenomics and Personalized Medicine Signal Transduction Pathways and Transcription Factors as Therapeutic Targets in Inflammatory Disease: Towards Innovative Antirheumatic Therapy
Current Pharmaceutical Design Modulation of MMP-9 Pathway by Lycopene in Macrophages and Fibroblasts Exposed to Cigarette Smoke
Inflammation & Allergy - Drug Targets (Discontinued) Lung Dendritic Cells: Targets for Therapy in Allergic Disease
Current Molecular Medicine Prevalence of Intestinal Parasites among Patients with Chronic Urticaria in Northern Iran
Infectious Disorders - Drug Targets Personalized Therapies in Pediatric Inflammatory and Autoimmune Diseases
Current Pharmaceutical Design In-silico Inhibitory Study of cFos-cJun Complex by T-5224 Based Small Molecule Analogs
Letters in Drug Design & Discovery Cost-minimization Analysis of Drugs Used in the Treatment of Asthma and COPD Diseases in India
Current Drug Therapy New Insights into Invasive Aspergillosis - from the Pathogen to the Disease
Current Pharmaceutical Design Anti-inflammatory Action of Green Tea
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Does Inhaled Corticosteroid Treatment Result in a Secondary Immune Deficiency Predisposing To Recurrent Infections?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Advances in Development of Phosphatidylinositol 3-Kinase Inhibitors
Current Medicinal Chemistry High Sensitivity C-Reactive Protein as a Potential Biomarker of Neuroinflammation in Major Psychiatric Disorders
Current Psychiatry Reviews Anti-Inflammatory Treatments for Chronic Diseases: A Review
Inflammation & Allergy - Drug Targets (Discontinued)